Literature DB >> 8490240

Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies.

M Kotani1, I Kawashima, H Ozawa, T Terashima, T Tai.   

Abstract

We investigated the localization of major gangliosides in adult rat brain by an immunofluorescence technique with mouse monoclonal antibodies (MAbs). Five MAbs (GMB16, GMR17, GGR12, GMR5 and GMR13) that specifically recognize gangliosides GM1, GD1a, GD1b, GT1b and GQ1b, respectively, were used. We have found that there is a cell type-specific expression of the ganglioside in the rat central nervous system. In cerebellar cortex, GM1 was expressed in myelin and some glial cells. GD1a was detected exclusively in the molecular layer. GD1b and GQ1b were present restrictedly on the granular layer; GD1b was detected on the surface of the granular cell bodies, whereas GQ1b was present in the cerebellar glomerulus. GT1b was distributed intensely in both the molecular layer and the granular layer. In cerebral cortex, GM1 was detected in some glial cells. Dense staining was limited to the white matter. GD1a was distributed in layers I, II/III and Va, and the upper part of layer VI, whereas GQ1b was localized in layers IV and Vb, and the lower part of layer VI. GD1b was detected beneath layer III. GT1b appeared to be distributed throughout all layers. In other regions, such as hippocampal formation and spinal cord, the expression of the ganglioside was also highly localized to a specific cell type and layer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490240     DOI: 10.1093/glycob/3.2.137

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  38 in total

1.  A case of Guillain-Barré syndrome associated with cerebellar ataxia and positive serum anti-GD1b IgG antibody.

Authors:  Hideki Sugimoto; Nobuo Wakata; Masahiko Kishi; Toshiki Fujioka; Teruyuki Kurihara; Yukiko Irie; Toyokazu Saito
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

2.  Molecular Microscopy of Brain Gangliosides: Illustrating their Distribution in Hippocampal Cell Layers.

Authors:  Benoit Colsch; Shelley N Jackson; Sucharita Dutta; Amina S Woods
Journal:  ACS Chem Neurosci       Date:  2011-02-21       Impact factor: 4.418

Review 3.  Imaging mass spectrometry for visualization of drug and endogenous metabolite distribution: toward in situ pharmacometabolomes.

Authors:  Yuki Sugiura; Mitsutoshi Setou
Journal:  J Neuroimmune Pharmacol       Date:  2009-06-11       Impact factor: 4.147

Review 4.  Biosynthesis and functions of gangliosides: recent advances.

Authors:  K O Lloyd; K Furukawa
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

5.  Localization and imaging of gangliosides in mouse brain tissue sections by laserspray ionization inlet.

Authors:  Alicia L Richards; Christopher B Lietz; James Wager-Miller; Ken Mackie; Sarah Trimpin
Journal:  J Lipid Res       Date:  2012-01-18       Impact factor: 5.922

6.  Locating lipids in the CNS: an historical perspective.

Authors:  B I Roots
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

Review 7.  Roles of gangliosides in mouse embryogenesis and embryonic stem cell differentiation.

Authors:  Dong Hoon Kwak; Byoung Boo Seo; Kyu Tae Chang; Young Kug Choo
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

8.  AP-MALDI Mass Spectrometry Imaging of Gangliosides Using 2,6-Dihydroxyacetophenone.

Authors:  Shelley N Jackson; Ludovic Muller; Aurelie Roux; Berk Oktem; Eugene Moskovets; Vladimir M Doroshenko; Amina S Woods
Journal:  J Am Soc Mass Spectrom       Date:  2018-03-16       Impact factor: 3.109

9.  GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neurons.

Authors:  Eun S Chung; Eugene Bok; Sunghyang Sohn; Young D Lee; Hyung H Baik; Byung K Jin
Journal:  BMC Neurosci       Date:  2010-06-12       Impact factor: 3.288

10.  Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice.

Authors:  Laleh Saadat; Jeffrey L Dupree; John Kilkus; Xianlin Han; Maria Traka; Richard L Proia; Glyn Dawson; Brian Popko
Journal:  Glia       Date:  2010-03       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.